SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

ACOSTA GARCIA, Edgar. Obesidad, tejido adiposo y resistencia a la insulina. Acta bioquím. clín. latinoam. [online]. 2012, vol.46, n.2, pp. 183-194. ISSN 0325-2957.

    1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-7. [ Links ]

    2. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428-35. [ Links ]

    3. Ezquerra EA, Castellano JM, Barrero AA. Obesidad, síndrome metabólico y diabetes: implicaciones cardiovasculares y actuación terapéutica. Rev Esp Cardiol 2008; 61(7): 752-64. [ Links ]

    4. Bornstein SR, Abu-Asab M, Glasow A, Path G, Hauner H, Tsokos M, et al. Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes 2000; 49: 532-8 [ Links ]

    5. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-30. [ Links ]

    6. Weisberg S, McCann D, Desai M, Rosenbaum M, Leibel R, Ferrante A. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003: 112(12): 1796-808. [ Links ]

    7. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6 (10): 772-83. [ Links ]

    8. Wellen K, Hotamisligil G. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112(12): 1785-8. [ Links ]

    9. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347-55. [ Links ]

    10. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW, DeFuria J, Jick Z. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007; 56: 2910-8. [ Links ]

    11. Surmi BK, Hasty AH. Macrophage infiltration into adipose tissue: initiation, propagation and remodelling. Future Lipidol 2008 ; 3(5): 545-56. [ Links ]

    12. Redinger RN. The physiology of adiposity. J Ky Med Assoc 2008; 106 (2): 53-62. [ Links ]

    13. Bays H, González J, Bray G, Kitabchi A, Bergman D, Schorr A, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008; 6(3): 343-68. [ Links ]

    14. Bays HE, Chapman RH, Grande S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007; 61(5): 737-47. [ Links ]

    15. World Health Organisation. Obesity. Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva, Switzerland, June 3-5, 1998. Geneva, Switzerland: WHO; 1998. [ Links ]

    16. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth referente for school-aged children and adolescents. Bull World Health Organization 2007; 85: 660-7. [ Links ]

    17. Ruderman NB, Schneider SH, Berchtold P. The "metabolically obese", normal-weight individual. Am J Clin Nutr 1981; 34: 1617-21. [ Links ]

    18. Karelis AD, Faraj B, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145-50. [ Links ]

    19. Cinti S. The role of brown adipose tissue in human obesity. Nutr Metab Cardiovasc Dis 2006; 16: 569-74. [ Links ]

    20. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: What do we know? J Clin Endocrinol Metab 2004; 89: 2569-75. [ Links ]

    21. Doelle G. The clinical picture of metabolic syndrome. An update on this complex of conditions and risk factors. Posgrad Med 2004; 116: 30-8. [ Links ]

    22. Chacín L, Chacín N, Chapín J. Vigencia del síndrome metabólico. Diabetes Internacional 2009; 1(4): 86-98. [ Links ]

    23. Despres JP. Health consequences of visceral obesity. Ann Med 2001; 3: 534-41. [ Links ]

    24. Frayn KN. Adipose tissue and the insulin resistente syndrome. Proc Nutr Soc 2001; 60: 375-80. [ Links ]

    25. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance. Diabetologia 2000; 43: 1498-1506. [ Links ]

    26. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89(6): 2583-9. [ Links ]

    27. Bays H, Blonde L, Rosenson R. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Cardiovasc Ther 2006; 4(6): 871-95. [ Links ]

    28. Tan GD, Goossens GH, Humphreys SM, Vidal H, Karpe F. Upper and lower body adipose tissue function: A direct comparison of fat mobilization in humans. Obesity Research 2004; 12: 114-8. [ Links ]

    29. Kougias P, Chai H, Lin PH, Yao O, Lumsden AB, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: Implication of vascular disease. J Surg Res 2005; 126: 121-9. [ Links ]

    30. Schffler A, Mller-Ladner U, Schlmerich J, Bchler C. Role of adipose tissue as an inflammatory organ in human diseases. Endocrinol Rev 2006: 27; 449-67. [ Links ]

    31. Miner JL. The adipocyte as an endocrine cell. J Anim Sci 2004; 82: 935-41. [ Links ]

    32. Bellizzi MC, Dietz WH. Workshop on childhood obesity: summary of the discussion. Am J Clin Nutr 1999; 70: 173s-5s. [ Links ]

    33. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240- 3. [ Links ]

    34. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28. [ Links ]

    35. Shiwaku K, Anuurad E, Enkhmaa B, Kitajima K, Yamane Y. Appropiate BMI for Asian populations. Lancet 2004; 363: 157-63. [ Links ]

    36. Zimmet G, Alberti KG, Serrano M. Una definición mundial del síndrome metabólico propuesta por la Federación Internacional de Diabetes: Fundamentos y resultados. Rev Esp Cardiol 2005: 1371-6. [ Links ]

    37. Chacín L, Chacín N, Chapín J. Vigencia del síndrome metabólico. Diabetes Internacional 2009; 1(4): 86-98. [ Links ]

    38. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz W H. Prevalence of a metabolic syndrome phenotype in adolescents. Finding from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157: 821-7. [ Links ]

    39. McCarthy HD, Ellis SM, Cole TJ. Central overweight and obesity in British youth aged 11 - 16 years: cross sectional surveys of waist circumference. BMJ 2003; 326: 624-7. [ Links ]

    40. Mora-Orta S, Corado J. Inmunología actual: Bases fisiológicas para la comprensión de las alteraciones del sistema inmunitario. Valencia-Venezuela: Alfa Impresores; 2003. [ Links ]

    41. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistence. Eur Cytokine Netw 2006; (1): 4-12. [ Links ]

    42. Kern PA, Ranganathan S, Li C,WoodL, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: 745-51. [ Links ]

    43. Fain JN, Bahouth SW, Madan AK. TNF-a release by the nonfat cells of human adipose tissue. Int J Obesity 2004; 28: 616-22. [ Links ]

    44. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000; 11(6): 212-7. [ Links ]

    45. Marcano Y, Torcat J, Ayala L, Verdi B, Lairet C, Maldonado M. Funciones endocrinas del tejido adiposo. Rev Venez Endocrinol Metab 2006; 4(1): 15-21. [ Links ]

    46. Long SD, Pekala PH. Regulation of GLUT4 mRNA stability by tumor necrosis factor-alpha: alterations in both protein binding to the 3' untranslated region and initiation of translation. Chem Biophys Res Commun 1996; 220 (3): 949-53. [ Links ]

    47. Ruan H, Hacohen N, Golub TR, Van Parijs, Lodish HF. Tumor necrosis factor alpha suppresses adipocyte genes in 3T3-L1 adipocytes: nuclear factor kappa B activation by TNF-alpha is obligatory. Diabetes 2002; 51: 1319-36. [ Links ]

    48. Montague CT, Prins JB, Sanders L, Zhang J, Setter CP, Digby J, et al. Depot-related gene expresión in human subcutaneous and omental adipocytes. Diabetes 1998; 47: 1384-92. [ Links ]

    49. Dusserre E, Moulin P, Vidal H. Differences in mRNA expression of the protein secreted in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000; 35; 1500-10. [ Links ]

    50. Koistinen HA, Bastard JP, Dusserre E, Ebeling P, Zegari N, Andreelli F, et al. Subcutaneous adipose tissue expresión of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects. Eur J Clin Invest 2000; 30: 302-10. [ Links ]

    51. Mohammed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-208. [ Links ]

    52. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistence. J Clin Invest 1995; 95: 2409-15. [ Links ]

    53. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspectiva based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448-54. [ Links ]

    54. Pérez MM. El adipocito como órgano endocrino. Implicaciones fisiopatológicas y terapéuticas. Rev Med 2007; 15(2): 225-42. [ Links ]

    55. Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847-50. [ Links ]

    56. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338-42. [ Links ]

    57. Kershaw E. Flier J. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89(6): 2548-56. [ Links ]

    58. Kroder G, Bossenmaier B, Keller M, Capp E, Stoyanov B, Muhlofer A, et al. Tumor necrosis factor-alpha and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signalling. J Clin Invest 1996; 97: 1471. [ Links ]

    59. Mooney Ra, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, et al. Suppressors of cytokine signaling-1 and IL-6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistence. J Biol Chem 2001; 276: 2588. [ Links ]

    60. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F. Evidence for a link between adipose tissue IL-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 1999; 99(16): 2221-2. [ Links ]

    61. Valle M, Martos R, Morales R. Obesidad infantil: una situación de riesgo? Rev Esp Obes 2005; 3(6): 340-51. [ Links ]

    62. Eckel RH. Lipoprotein lipase. A multifuntional enzyme relevant to common metabolic diseases. N Engl J Med 1989; 320: 1060-8. [ Links ]

    63. Jensen MD, Caruso M, Heiling V, Miles JM. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 1989; 38: 1595-601. [ Links ]

    64. Assy N, Nassar F, Nasser G, Grosovski M. Olive in consumption and non-alcoholic fatty liver disease. World J Gastroenterol 2009; 15(15): 1809-15. [ Links ]

    65. Kim YB, Shulman GI, Kahn BB. Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda/zeta but not on glycogen synthase kinase-3. J Biol Chem 2002; 277: 32915-22. [ Links ]

    66. Grasa U, Rite G, Grasa B, Tello M, Rite S. Valores de referencia de interleucina-6 (IL-6) y factor de necrosis tumoral alfa (TNF-a) en recién nacidos sanos. An Esp Pediatr 2001; 54: 526-7. [ Links ]

    67. Molnar D, Decsi T, Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes Relat Metab Disord 2004; 28: 1197-202. [ Links ]

    68. Higdon JV, Frei B. Obesity and oxidative stress: a direct link to CVD? Arterioscler Thromb Vasc Biol 2003; 23: 365-7. [ Links ]

    69. Kohen R, Nyska A. Oxidation of biological system: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002; 30(6): 620-50. [ Links ]

    70. Stadtman ER. Rol of oxidant species in aging. Curr Med Chem 2004; 11: 1105-12. [ Links ]

    71. Rodrigo R, Guichard C, Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol 2007; 21: 111-27. [ Links ]

    72. Panagiotakos DB, Chrysohoou C, Pitsavos C, Stefanadis C. Association between the prevalence of obesity and adherente to the Mediterranean diet: the ATTICA study. Nutrition 2006; 22: 449-56. [ Links ]

    73. Sanchez-Villegas A, Bes-Rastrollo M, Martinez-Gonzalez MA, Serra-Majem L. Adherence to a Mediterranean dietary pattern and weight gain in a follow-up study: the SUN cohort. Int J Obes (Lond) 2006; 30: 350-8. [ Links ]

    74. Tortosa A, Bes-Rastrollo M, Sanchez-Villegas A, Basterra-Gortari FJ, Nunez-Cordoba JM, Martinez-Gonzalez MA. Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort. Diabetes Care 2007; 30: 2957-9. [ Links ]

    75. de Souza Valente da Silva L, Valeria da Veiga G, Ramalho RA. Association of serum concentrations of retinol and carotenoids with overweight in children and adolescents. Nutrition 2007; 23(5): 392-7. [ Links ]

    76. Suzuki K, Inoue T, Hioki R, Ochiai J, Kusuhara Y, Ichino N, et al. Association of abdominal obesity with decreased serum levels of carotenoids in a healthy Japanese population. Clin Nutr 2006; 25: 780-9. [ Links ]

    77. Aasheim ET, Hofso D, Hjelmesaeth J, Birkeland KI, Bohmer T. Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 2008; 87: 362-9. [ Links ]

    78. Ozata M, Mergen M, Oktenli C, Aydin A, Sanisoglu SY, Bolu E, et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem 2002; 35: 627-31. [ Links ]

    79. Erdeve O, Siklar Z, Kocaturk PA, Dallar Y, Kavas GO. Antioxidant superoxide dismutase activity in obese children. Biol Trace Elem Res 2004; 98: 219-28. [ Links ]

    80. Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002; 26: 1159-64. [ Links ]

    81. Lazarevic G, Antic S, Cvetkovic T, Vlahovic P, Tasic I, Stefanovic V. A physical activity programme and its effects on insulin resistance and oxidative defense in obese male patients with type 2 diabetes mellitus. Diabetes Metab 2006; 32: 583-90. [ Links ]

    82. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-61. [ Links ]

    83. Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, Egan BM. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 2003; 41: 422-30. [ Links ]

    84. Beltowski J, Wojcicka G, Gorny D, Marciniak A. The effect of dietary-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol 2000; 51: 883-96. [ Links ]

    85. Fortuño A, San José G, Moreno MU, Beloqui O, Díez J, Zalba G. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes 2006; 55: 209-15. [ Links ]

    86. Katsuki A, Suematsu M, Gabazza EC, Murashima S, Nakatani K, Togashi K, et al. Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract 2006; 73: 310-4. [ Links ]

    87. Wolf D. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95. [ Links ]

    88. Sonnenberg GE, Krakower GR, Kissebath AH. A novel pathway to the manifestations of metabolic syndrome. Obes Res 2004; 12: 180-6. [ Links ]

    89. Scherck R, Baeuerle PA. Reactive oxygen intermediates as apparentely widely used messengers in the activation of NF-kB transcription factor and HIV-1. Trends Cell Biol 1991; 1: 39-42. [ Links ]

    90. Rodríguez-Rodríguez E, Perea JM, López-Sobaler AM, Ortega RM. Obesidad, resistencia a la insulina y aumento de los niveles de adipoquinas: importancia de la dieta y el ejercicio físico. Nutr Hosp 2009; 24(4): 415-21. [ Links ]

    91. Raffaella C, Francesca B, Italia F, Marina P, Giovanna L, Susana I. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity (Silver Spring) 2008; 16: 958-64. [ Links ]

    92. Pomplun D, Voigt A, Schulz TJ, Thierbach R, Pfeiffer AF, Ristow M. Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity. Proc Nat Acad Sciences (USA) 2007; 104: 6377-81. [ Links ]

    93. Koh EH, Park JY, Park HS, Jeon MJ, Ryu JW, Kim M, et al. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 2007; 56: 2973-81. [ Links ]

    94. Bevilacqua L, Ramsey JJ, Hagopian K, Weindruch R, Harper ME. Long-term caloric restriction increases UCP3 content but decreases proton leak and reactive oxygen species production in rat skeletal muscle mitochondria. Am J Physiol 2005; 289: E429-E438. [ Links ]

    95. Vincent HK, Innes KE, Vincent KR. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007; 9: 813-39. [ Links ]

    96. Rodrigo R, Guichard C, Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol 2007; 21: 111-27. [ Links ]

    97. Visioli F, Riso P, Grande S, Galli C, Porrini M. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr 2003; 42: 201-6. [ Links ]

    98 Fito M, De La Torre R, Farre-Albaladejo M, Khymenetz O, Marrugat J, Covas MI. Bioavailability and antioxidant effects of olive oil phenolic compounds in humans: a review. Ann Ist Super Sanita 2007; 43: 375-81. [ Links ]

    99. Mayne S. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr 2003; 133(3): 933- 40. [ Links ]

    100. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004; 142: 231-55. [ Links ]

    101. Barbosa K, Bressan J, Zulet M, Martínez J. Influencia de la dieta sobre marcadores plasmáticos de estrés oxidativo en humanos. An Sist Sanit Navar 2008; 31 (3): 259-80. [ Links ]

    102. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999; 99: 1141-6. [ Links ]

    103. Domínguez Z. Los prostanoides, una revolución autocoide. An Venez Nutr 2006; 19(2): 74-82. [ Links ]

    104. Reilly MP, Lawson JA, Fitzgerald GA. Eicosanoids and isoeicosanoids: Indices of cellular function and oxidant stress. J Nutr 1998; 128(2): 434-8. [ Links ]

    105. Sodergren E, Cederberg J, Basu S, Vessby B. Vitamin E supplementation decreases basal levels of F(2)-isoprostanes and prostaglandin f(2alpha) in rats. J Nutr 2000; 130: 10-4. [ Links ]

    106. Yin H, Musiek E, Morrow J. Quantification of isoprostanes as an index of oxidative stress: A update. J Biol Scien 2006; 6(3): 469-79. [ Links ]

    107. Mayne S. Antioxidant nutrients and chronic disease: Use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr 2003; 133: 933-40. [ Links ]

    108. Reilly M, Delanty N, Lawson J A, Fitzgerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94: 19-25. [ Links ]